Hajir A Al Saihati (Hajir AlSaihati)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 16

Top Topics

Polycyclic Aromatic Hydrocarbons

Prostate Cancer

Top Venues

Current oncology (Toronto, Ont.)

Molecules (Basel, Switzerland)

Medicina (Kaunas, Lithuania)

This page only lists publications with an associated author ORCID identifier.

Publications

Ali A Rabaan, Hajir A Al Saihati, Rehab Bukhamsin, Muhammed A Bakhrebah, Majed S Nassar, Abdulmonem A Alsaleh, Yousef N Alhashem, Ammar Y Bukhamseen, Khalil Al-Ruhimy, Mohammed Alotaibi, Roua A Alsubki, Hejji E Alahmed, Saleh Al-Abdulhadi, Fatemah A Alhashem, Ahlam A Alqatari, Ahmed Alsayyah, Ramadan Abdelmoez Farahat, Rwaa H Abdulal, Ali H Al-Ahmed, Mohd Imran, Ranjan K Mohapatra
Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction. Current oncology (Toronto, Ont.) 30 (2) (2023)
Ali A Rabaan, Hajir A Al Saihati, Rehab Bukhamsin, Muhammed A Bakhrebah, Majed S Nassar, Abdulmonem A Alsaleh, Yousef N Alhashem, Ammar Y Bukhamseen, Khalil Al-Ruhimy, Mohammed Alotaibi, Roua A Alsubki, Hejji E Alahmed, Saleh Al-Abdulhadi, Fatemah A Alhashem, Ahlam A Alqatari, Ahmed Alsayyah, Ramadan Abdelmoez Farahat, Rwaa H Abdulal, Ali H Al-Ahmed, Mohd Imran, Ranjan K Mohapatra
Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction. Current oncology (Toronto, Ont.) 30 (2) (2023)
Ali A Rabaan, Hajir A Al Saihati, Rehab Bukhamsin, Muhammed A Bakhrebah, Majed S Nassar, Abdulmonem A Alsaleh, Yousef N Alhashem, Ammar Y Bukhamseen, Khalil Al-Ruhimy, Mohammed Alotaibi, Roua A Alsubki, Hejji E Alahmed, Saleh Al-Abdulhadi, Fatemah A Alhashem, Ahlam A Alqatari, Ahmed Alsayyah, Ramadan Abdelmoez Farahat, Rwaa H Abdulal, Ali H Al-Ahmed, Mohd Imran, Ranjan K Mohapatra
Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction. Current oncology (Toronto, Ont.) 30 (2) (2023)
Hajir A Al Saihati, Hosni A M Hussein, Ali A Thabet, Ahmed A Wardany, Sabry Younis Mahmoud, Eman S Farrag, Taha I A Mohamed, Samah M Fathy, Mohamed E Elnosary, Ali Sobhy, Abdelazeem E Ahmed, Ahmed M El-Adly, Fareed S El-Shenawy, Asmaa A Elsadek, Amal Rayan, Zeinab Albadry M Zahran, Omnia El-Badawy, Mohamed G M El-Naggar, Magdy M Afifi, Asmaa M Zahran
Memory T Cells Discrepancies in COVID-19 Patients. Microorganisms 11 (11) (2023)
Ali A Rabaan, Hajir A Al Saihati, Rehab Bukhamsin, Muhammed A Bakhrebah, Majed S Nassar, Abdulmonem A Alsaleh, Yousef N Alhashem, Ammar Y Bukhamseen, Khalil Al-Ruhimy, Mohammed Alotaibi, Roua A Alsubki, Hejji E Alahmed, Saleh Al-Abdulhadi, Fatemah A Alhashem, Ahlam A Alqatari, Ahmed Alsayyah, Ramadan Abdelmoez Farahat, Rwaa H Abdulal, Ali H Al-Ahmed, Mohd Imran, Ranjan K Mohapatra
Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction. Current oncology (Toronto, Ont.) 30 (2) (2023)
Ali A Rabaan, Hajir A Al Saihati, Rehab Bukhamsin, Muhammed A Bakhrebah, Majed S Nassar, Abdulmonem A Alsaleh, Yousef N Alhashem, Ammar Y Bukhamseen, Khalil Al-Ruhimy, Mohammed Alotaibi, Roua A Alsubki, Hejji E Alahmed, Saleh Al-Abdulhadi, Fatemah A Alhashem, Ahlam A Alqatari, Ahmed Alsayyah, Ramadan Abdelmoez Farahat, Rwaa H Abdulal, Ali H Al-Ahmed, Mohd Imran, Ranjan K Mohapatra
Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction. Current oncology (Toronto, Ont.) 30 (2) (2023)
Ali A Rabaan, Hajir A Al Saihati, Rehab Bukhamsin, Muhammed A Bakhrebah, Majed S Nassar, Abdulmonem A Alsaleh, Yousef N Alhashem, Ammar Y Bukhamseen, Khalil Al-Ruhimy, Mohammed Alotaibi, Roua A Alsubki, Hejji E Alahmed, Saleh Al-Abdulhadi, Fatemah A Alhashem, Ahlam A Alqatari, Ahmed Alsayyah, Ramadan Abdelmoez Farahat, Rwaa H Abdulal, Ali H Al-Ahmed, Mohd Imran, Ranjan K Mohapatra
Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction. Current oncology (Toronto, Ont.) 30 (2) (2023)
Naveed Ahmed, Mai Abdel Haleem A Abusalah, Anam Farzand, Muhammad Absar, Nik Yusnoraini Yusof, Ali A Rabaan, Hajir A Al Saihati, Amer Mohammad Alshengeti, Sara Alwarthan, Haifa S Alsuwailem, Zainb A Alrumaih, Ahmed Alsayyah, Chan Yean Yean
Updates on Epstein-Barr Virus (EBV)-Associated Nasopharyngeal Carcinoma: Emphasis on the Latent Gene Products of EBV. Medicina (Kaunas, Lithuania) 59 (1) (2022)
Naveed Ahmed, Mai Abdel Haleem A Abusalah, Anam Farzand, Muhammad Absar, Nik Yusnoraini Yusof, Ali A Rabaan, Hajir A Al Saihati, Amer Mohammad Alshengeti, Sara Alwarthan, Haifa S Alsuwailem, Zainb A Alrumaih, Ahmed Alsayyah, Chan Yean Yean
Updates on Epstein-Barr Virus (EBV)-Associated Nasopharyngeal Carcinoma: Emphasis on the Latent Gene Products of EBV. Medicina (Kaunas, Lithuania) 59 (1) (2022)
Ali A Rabaan, Rehab Bukhamsin, Hajir A Al Saihati, Saleh A Alshamrani, Jehad AlSihati, Hani M Al-Afghani, Roua A Alsubki, Abdulmonem A Abuzaid, Saleh Al-Abdulhadi, Yahya Aldawood, Abdulmonem A Alsaleh, Yousef N Alhashem, Jenan A Almatouq, Talhah Bin Emran, Shamsah H Al-Ahmed, Firzan Nainu, Ranjan K Mohapatra
Recent Trends and Developments in Multifunctional Nanoparticles for Cancer Theranostics. Molecules (Basel, Switzerland) 27 (24) (2022)
Naveed Ahmed, Mai Abdel Haleem A Abusalah, Anam Farzand, Muhammad Absar, Nik Yusnoraini Yusof, Ali A Rabaan, Hajir A Al Saihati, Amer Mohammad Alshengeti, Sara Alwarthan, Haifa S Alsuwailem, Zainb A Alrumaih, Ahmed Alsayyah, Chan Yean Yean
Updates on Epstein-Barr Virus (EBV)-Associated Nasopharyngeal Carcinoma: Emphasis on the Latent Gene Products of EBV. Medicina (Kaunas, Lithuania) 59 (1) (2022)
Naveed Ahmed, Mai Abdel Haleem A Abusalah, Anam Farzand, Muhammad Absar, Nik Yusnoraini Yusof, Ali A Rabaan, Hajir A Al Saihati, Amer Mohammad Alshengeti, Sara Alwarthan, Haifa S Alsuwailem, Zainb A Alrumaih, Ahmed Alsayyah, Chan Yean Yean
Updates on Epstein-Barr Virus (EBV)-Associated Nasopharyngeal Carcinoma: Emphasis on the Latent Gene Products of EBV. Medicina (Kaunas, Lithuania) 59 (1) (2022)
Ali A Rabaan, Rehab Bukhamsin, Hajir A Al Saihati, Saleh A Alshamrani, Jehad AlSihati, Hani M Al-Afghani, Roua A Alsubki, Abdulmonem A Abuzaid, Saleh Al-Abdulhadi, Yahya Aldawood, Abdulmonem A Alsaleh, Yousef N Alhashem, Jenan A Almatouq, Talhah Bin Emran, Shamsah H Al-Ahmed, Firzan Nainu, Ranjan K Mohapatra
Recent Trends and Developments in Multifunctional Nanoparticles for Cancer Theranostics. Molecules (Basel, Switzerland) 27 (24) (2022)
Ali A Rabaan, Rehab Bukhamsin, Hajir A Al Saihati, Saleh A Alshamrani, Jehad AlSihati, Hani M Al-Afghani, Roua A Alsubki, Abdulmonem A Abuzaid, Saleh Al-Abdulhadi, Yahya Aldawood, Abdulmonem A Alsaleh, Yousef N Alhashem, Jenan A Almatouq, Talhah Bin Emran, Shamsah H Al-Ahmed, Firzan Nainu, Ranjan K Mohapatra
Recent Trends and Developments in Multifunctional Nanoparticles for Cancer Theranostics. Molecules (Basel, Switzerland) 27 (24) (2022)
Ali A Rabaan, Muhammed A Bakhrebah, Hajir A Al Saihati, Saad Alhumaid, Roua A Alsubki, Safaa A Turkistani, Saleh Al-Abdulhadi, Yahya Aldawood, Abdulmonem A Alsaleh, Yousef N Alhashem, Jenan A Almatouq, Ahlam A Alqatari, Hejji E Alahmed, Dalal A Sharbini, Arwa F Alahmadi, Fatimah Alsalman, Ahmed Alsayyah, Abbas Al Mutair
Artificial Intelligence for Clinical Diagnosis and Treatment of Prostate Cancer. Cancers 14 (22) (2022)
Ali A Rabaan, Rehab Bukhamsin, Hajir A Al Saihati, Saleh A Alshamrani, Jehad AlSihati, Hani M Al-Afghani, Roua A Alsubki, Abdulmonem A Abuzaid, Saleh Al-Abdulhadi, Yahya Aldawood, Abdulmonem A Alsaleh, Yousef N Alhashem, Jenan A Almatouq, Talhah Bin Emran, Shamsah H Al-Ahmed, Firzan Nainu, Ranjan K Mohapatra
Recent Trends and Developments in Multifunctional Nanoparticles for Cancer Theranostics. Molecules (Basel, Switzerland) 27 (24) (2022)